Novel targeted therapies for Parkinson’s disease

Parkinson’s disease (PD) is the second more common neurodegenerative disease with increasing incidence worldwide associated to the population ageing. Despite increasing awareness and significant research advancements, treatment options comprise dopamine repleting, symptomatic therapies that have sig...

Descripción completa

Detalles Bibliográficos
Autores principales: Ntetsika, Theodora, Papathoma, Paraskevi-Evita, Markaki, Ioanna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7905684/
https://www.ncbi.nlm.nih.gov/pubmed/33632120
http://dx.doi.org/10.1186/s10020-021-00279-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7905684/
https://www.ncbi.nlm.nih.gov/pubmed/33632120
http://dx.doi.org/10.1186/s10020-021-00279-2

Ejemplares similares